Tri-Supply
Tri-supply is a joint venture company set up by Gilead Sciences Ltd and Lawrence Laboratories. The company was incorporated in January 2007.
It was set up to produce Atripla which is a combination of Sustiva, manufactured by Lawrence Laboratories and Truvada, manufactured by Gilead Sciences Limited. Atripla is the company’s only product.
It was the first once-daily single tablet regimen for HIV-1 infection intended as a stand-alone therapy or in combination with other antiretrovirals.
Financial Data
-
31st Dec 18 Source: CRO
- €37.5 million turnover
-
€25,600
profit
-
31st Dec 17 Source: CRO
- €72.7 million turnover
-
€37,763
profit
- 7 more years available »
Ranking
By Turnover
(€37.5 million)- 753rd in Top Companies
- 74th in Pharma
-
- €37.5 million
Employees
- David Cadogan Vice President}
Latest News
- 6:43am Unaffordable apartments, fluffy TV and how to reduce your tax bill this year
- 5:30am HR tech company Personio to create 140 jobs in Dublin
- 5:04am Residential property transactions fell sharply last year
- 1:00am Cost to develop Dublin city apartment as much as €619,000
- Jan 25 Deutsche Bank to conduct internal investigation over risky investments